ArticleRevista Cuidarte
[Factors Associated with Diabetes Mellitus Screening in Peruvian Population: A public health problem?Fatores associados a triagem da Diabetes Mellitus na populado Peruana: um problema de saúde pública?]
Article in Revista Cuidarte. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diabetes Mellitus screening and associated factors in Peru: A cross-sectional analysis of a national health survey.PLOS global public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Type 2 Diabetes Mellitus (T2DM) is a disease that poses a challenge to public health due to its growth trend and impact, especially in developing countries. This study aimed to determine the factors associated with not being screened for T2DM according to the 2020 Demographic and Family Health Survey (ENDES-2020). Materials and Methods: Secondary, cross-sectional, analytical study using the ENDES-2020 data. Results: The variables that showed a statistically significant association for T2DM screening were the following: male sex (PR=1.06, 95% CI: 1.02-1.10; p<0.001), ages between 30 and 59 years (0.92, 95% CI: 0.89-0.95; p<0.001) and 60 years and older (PR=0.72, 95% CI: 0.65-0.79; p<0.001), primary education (PR=0.94, 95% CI: 0.92-0.99; p<0.020), secondary education (PR=0.93, 95% CI: 0.88-0.97; p=0.008) higher education (PR=0.86, 95% CI: 0.85-0.94; p<0.001), poor (PR=0.96, 95% CI: 0.92-0.99; p=0.016), middle income (PR=0.93, 95% CI: 0.88-0.96; p=0.001), rich (PR=0.89, 95% CI: 0.84-0.94; p<0.001), very rich (PR=0.81, 95% CI: 0.75-0.86; p<0.001), and hypertension (PR=0.91, 95% CI: 0.867-0.969; p=0.002). Discussion: Being male was the only factor associated with not being screened for T2DM, whereas belonging to an older age group, having arterial hypertension, and having higher education and socioeconomic levels increased the possibility of being screened. Conclusion: It is essential to strengthening screening strategies at the primary level of care by implementing preventive measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.